Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants

BACKGROUND: There is a lack of data on anticoagulation requirements during ablation of atrial fibrillation (AF). This study compares different oral anticoagulation (OAC) strategies to evaluate risk of bleeding and thromboembolic complications. METHODS: We conducted a single-centre study in patients...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Cardiovasc Disord
Главные авторы: Brinkmeier-Theofanopoulou, Maria, Tzamalis, Panagiotis, Wehrkamp-Richter, Susan, Radzewitz, Andrea, Merkel, Matthias, Schymik, Gerhard, van Mark, Gesine, Bramlage, Peter, Schmitt, Claus, Luik, Armin
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5924498/
https://ncbi.nlm.nih.gov/pubmed/29703158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-018-0804-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы